Latest inflation figures are good news 
Unstable employment while you’re young can set you up for a wage gap later in life – even if you eventually land full-time work 
McDonald's Philippines Launches 'Ride the Arches' for Cyclists 
McDonald's Faces Backlash Over $5 Meal Deal: Customers Call It 'Skimpy' 
What kind of diner are you? 6 types of diners who avoid plant-based meat dishes 
Uganda’s tax system isn’t bringing in enough revenue but is targeting small business the answer? 
Reducing energy demand and improving efficiency will help prevent the next gas crisis 
How visas for social care workers may be exacerbating exploitation in the sector 
Nike vs. Adidas: Anthony Edwards’ and Wembanyama’s Sneakers Soar in Popularity 
If the RBA’s right, interest rates may not fall for another year. Here’s why. 
Mexico’s slow slide towards vigilante violence 
ALWAYTH x Adidas Samba: Revolutionizing Sneaker Culture with Fashion-Forward Collaboration 
How ‘social financing’ could help fund higher education for under-represented students 
Hindustan Unilever (HUL) will invest in Zywie Ventures (OZiva) and Nutritionalab (Wellbeing Nutrition) to enter the health and well-being business category.
Unilever’s Indian subsidiary will initially acquire a 51 percent equity stake in OZiva, before purchasing the rest in three years.
A plant-based and clean-label consumer wellness brand, OZiva supplies lifestyle protein, hair and beauty supplements, and women’s health solutions.
OZiva’s current team will continue to operate all business functions.
Meanwhile, HUL is buying a 19.8 percent interest in Wellbeing Nutrition. The company’s product range includes marine collagen powder, Melts oral strips and health capsules. The current Wellbeing Nutrition team, led by founder and CEO Avnish Chhabria, will continue to operate the business.
According to Sanjiv Mehta, HUL’s CEO and managing director, the strategic investments give them an entry into the fast-growing health and wellbeing category.
Mehta added that HUL is well-positioned to support further scale-up of these businesses through our R&D, market development, distribution capabilities, and Unilever’s global health and wellbeing expertise.
Both transactions are set for completion within three months.
